Evidence map›Paper›PMID 21984590›Full record

SynthesisJournal of the American Medical Informatics Association : JAMIA

The economics of health information technology in medication management: a systematic review of economic evaluations.

Daria O'Reilly, Jean-Eric Tarride, Ron Goeree, Cynthia Lokker, K Ann McKibbon

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of the American Medical Informatics Association : JAMIA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Cost-effectiveness analysis of a hospital electronic medication management system.Journal of the American Medical Informatics Association : JAMIA · 2015
    Article
  11. Health Information Economy: Literature Review.Global journal of health science · 2015
    Review
  12. Article
  13. Article
  14. Automated detection of retinal disease.The American journal of managed care · 2014
    Article
  15. Recent trends in biomedical informatics: a study based on JAMIA articles.Journal of the American Medical Informatics Association : JAMIA · 2013
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daria O'ReillyPrograms for Assessment of Technology in Health-PATH, Research Institute-St Joseph's Healthcare, Hamilton, Ontario, Canada. oreilld@mcmaster.ca
Jean-Eric Tarride
Ron Goeree
Cynthia Lokker
K Ann McKibbon

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo conduct a systematic review and synthesis of the evidence surrounding the cost-effectiveness of health information technology (HIT) in the medication process. MATERIALS AND

methodsPeer-reviewed electronic databases and gray literature were searched to identify studies on HIT used to assist in the medication management process. Articles including an economic component were reviewed for further screening. For this review, full cost-effectiveness analyses, cost-utility analyses and cost-benefit analyses, as well as cost analyses, were eligible for inclusion and synthesis.

resultsThe 31 studies included were heterogeneous with respect to the HIT evaluated, setting, and economic methods used. Thus the data could not be synthesized, and a narrative review was conducted. Most studies evaluated computer decision support systems in hospital settings in the USA, and only five of the studied performed full economic evaluations. DISCUSSION: Most studies merely provided cost data; however, useful economic data involves far more input. A full economic evaluation includes a full enumeration of the costs, synthesized with the outcomes of the intervention.

conclusionThe quality of the economic literature in this area is poor. A few studies found that HIT may offer cost advantages despite their increased acquisition costs. However, given the uncertainty that surrounds the costs and outcomes data, and limited study designs, it is difficult to reach any definitive conclusion as to whether the additional costs and benefits represent value for money. Sophisticated concurrent prospective economic evaluations need to be conducted to address whether HIT interventions in the medication management process are cost-effective.

Indexed as

Health Care CostsCost-Benefit AnalysisDecision Support Systems, ClinicalDrug Therapy, Computer-AssistedEconomics, HospitalEuropeHumansIsraelMedical Order Entry SystemsMedication SystemsNorth AmericaOutcome Assessment, Health CarePrimary Health CareReminder Systems

Identifiers

PMID21984590
PMCPMC3341783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.